JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations
JS InnoPharm, LLC
JS InnoPharm, LLC
NextPoint Therapeutics, Inc.
PACT Pharma, Inc.
Jiangsu HengRui Medicine Co., Ltd.
Mitra RxDx, Inc.
Betta Pharmaceuticals Co., Ltd.